Category Archives: Dubious statistics

Another Great Depression or Tax Justice and Transparency? The Tax Justice Network January 2020 Podcast

TaxCast ranges well beyond tax today, with topics including IMF warnings, the Brexit rogue UK vision, and looting in Angola.

China Coronavirus Watch: Updated – Another Chinese City Locked Down to Prevent Spread

A compilation of what seems to be known about the new Chinese coronavirus.

Precarity: A Political Problem

‘Free market’ advocates claim that the rise of precarity was inevitable, as opposed to the result of political decisions.

The Impact of CEOs in the Public Sector: Evidence from the English NHS

The myth of magical CEOs seems to break down in the public sector.

Conservative Win in Britain Means More Than Economic Trouble Ahead

In an uncertain economic context, the Conservative election win means a loss for health and the environment.

Inequality and Trade: Simulation Evidence for 54 Developing Nations

A full-throated defense of more liberalized trade for developing nations…when the data is somewhat mixed.

Oil and Gas Emissions Are Reversing Progress from Coal’s Decline

More grim emissions news….

Reports Of Patients’ Deaths Linked To Heart Devices Lurk Below Radar

Another KHN scoop on how the FDA has been hiding reports of bad outcomes with medical devices, in this case, ones for heart disease.

The Financialization of Child and Elder Care: The Tax Justice Network December 2019 Podcast

Private equity is moving in a big way into elder and child care services in the UK. Patients and parents beware.

Productivity Does Not Explain Wages

As long as we believe the neoclassical productivity farce, we will know nothing about what causes prices.

Bill Black: Lawrence O’Donnell Aims at Buttigieg, But Hits New Democrats

A takedown of the New Democrats’ love of austerity.

There is No Economics Without Politics

Debunking the pretense that the economics discipline is neutral or objective.

Financialization of the U.S. Pharmaceutical Industry

A takedown of the pharmaceutical industry’s assertion that it need to price gouge so it can invest in R&D. Profits go almost entirely to various forms of looting.